- Home
- CERS vs ASPI Comparison
CERS vs ASPI Comparison
Compare CERS & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- ASPI
- Stock Information
- Founded
- CERS 1991
- ASPI 2021
- Country
- CERS United States
- ASPI United States
- Employees
- CERS N/A
- ASPI N/A
- Industry
- CERS EDP Services
- ASPI Major Chemicals
- Sector
- CERS Technology
- ASPI Industrials
- Exchange
- CERS Nasdaq
- ASPI Nasdaq
- Market Cap
- CERS 347.3M
- ASPI 392.1M
- IPO Year
- CERS 1997
- ASPI 2022
- Fundamental
- Price
- CERS $1.30
- ASPI $5.84
- Analyst Decision
- CERS Strong Buy
- ASPI Strong Buy
- Analyst Count
- CERS 2
- ASPI 2
- Target Price
- CERS $3.50
- ASPI $4.50
- AVG Volume (30 Days)
- CERS 1.3M
- ASPI 2.2M
- Earning Date
- CERS 05-01-2025
- ASPI 05-14-2025
- Dividend Yield
- CERS N/A
- ASPI N/A
- EPS Growth
- CERS N/A
- ASPI N/A
- EPS
- CERS N/A
- ASPI N/A
- Revenue
- CERS $180,270,000.00
- ASPI $4,144,225.00
- Revenue This Year
- CERS $25.57
- ASPI $690.06
- Revenue Next Year
- CERS $10.54
- ASPI $93.09
- P/E Ratio
- CERS N/A
- ASPI N/A
- Revenue Growth
- CERS 15.29
- ASPI 857.04
- 52 Week Low
- CERS $1.12
- ASPI $1.86
- 52 Week High
- CERS $2.54
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- CERS 42.68
- ASPI 58.73
- Support Level
- CERS $1.12
- ASPI $4.18
- Resistance Level
- CERS $1.42
- ASPI $6.80
- Average True Range (ATR)
- CERS 0.11
- ASPI 0.79
- MACD
- CERS 0.01
- ASPI 0.14
- Stochastic Oscillator
- CERS 58.06
- ASPI 66.67
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.